Chemical myectomy with mavacamten in patients with obstructive hypertrophic cardiomyopathy with prior septal reduction therapy: A single-center experience

Authors

Prabhjot Hundal, Advocate Health - MidwestFollow
Zaid Abood, Advocate Health - MidwestFollow
Heather Sanders, Advocate Health - MidwestFollow
Amanda Misicka, Advocate Health - MidwestFollow
Patrycja Galazka, Advocate Health - MidwestFollow
Arshad Jahangir, Advocate Health - MidwestFollow
M Fuad Jan, Advocate Health - MidwestFollow
A Jamil Tajik, Advocate Health - MidwestFollow

Recommended Citation

Hundal P, Abood Z, Sanders H, et al. Chemical myectomy with mavacamten in patients with obstructive hypertrophic cardiomyopathy with prior septal reduction therapy: A single-center experience. JTCVS Open. 2025;27:58-61. Published 2025 Jul 19. doi:10.1016/j.xjon.2025.07.007

Affiliations

Aurora Sinai/Aurora St Luke's Medical Centers

Type

Article

PubMed ID

41169327